Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-serine Augmentation of Auditory Learning in Schizophrenia
NCT05046353Phase 2Suspended
- Sponsor
- New York State Psychiatric Institute
- Start
- Dec 2022
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-serine in schizophrenia, schizoaffective disorder, sponsored by New York State Psychiatric Institute. Started Dec 2022; status: suspended.
02
Drugs
d-serine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT05046353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05046353.